Terence M. Berge's most recent trade in Conmed Corp. was a trade of 8,000 Options To Purchase Common Stock done . Disclosure was reported to the exchange on March 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 8,000 | 8,000 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.76 per share. | 28 Apr 2023 | 5,400 | 14,604 (0%) | 0% | 78.8 | 425,304 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.96 per share. | 28 Apr 2023 | 5,400 | 9,204 (0%) | 0% | 60.0 | 323,784 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 5,400 | 2,700 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 5,400 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 126.42 per share. | 28 Apr 2023 | 5,400 | 6,104 (0%) | 0% | 126.4 | 682,668 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 126.78 per share. | 28 Apr 2023 | 5,400 | 11,504 (0%) | 0% | 126.8 | 684,612 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.69 per share. | 28 Apr 2023 | 5,100 | 19,704 (0%) | 0% | 97.7 | 498,219 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 5,100 | 5,100 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 126.65 per share. | 28 Apr 2023 | 5,100 | 1,004 (0%) | 0% | 126.7 | 645,915 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.93 per share. | 28 Apr 2023 | 2,800 | 3,804 (0%) | 0% | 41.9 | 117,404 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 2,800 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 127.44 per share. | 28 Apr 2023 | 2,800 | 16,904 (0%) | 0% | 127.4 | 356,832 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,000 | 8,000 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 10,000 | 10,000 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 12,000 | 12,000 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 122.50 per share. | 01 Mar 2021 | 5,400 | 1,004 (0%) | 0% | 122.5 | 661,500 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 5,400 | 8,100 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.76 per share. | 01 Mar 2021 | 5,400 | 6,404 (0%) | 0% | 78.8 | 425,304 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 3,860 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.87 per share. | 01 Mar 2021 | 3,860 | 4,864 (0%) | 0% | 39.9 | 153,898 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 122.77 per share. | 01 Mar 2021 | 3,860 | 1,004 (0%) | 0% | 122.8 | 473,903 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,800 | 2,800 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.93 per share. | 01 Mar 2021 | 2,800 | 3,804 (0%) | 0% | 41.9 | 117,404 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 122.53 per share. | 01 Mar 2021 | 2,800 | 1,004 (0%) | 0% | 122.5 | 343,075 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.96 per share. | 01 Mar 2021 | 2,700 | 3,704 (0%) | 0% | 60.0 | 161,892 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,700 | 5,400 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 122.50 per share. | 01 Mar 2021 | 2,700 | 1,004 (0%) | 0% | 122.5 | 330,750 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 97.69 per share. | 01 Mar 2021 | 2,550 | 3,554 (0%) | 0% | 97.7 | 249,110 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 122.50 per share. | 01 Mar 2021 | 2,550 | 1,004 (0%) | 0% | 122.5 | 312,375 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,550 | 10,200 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2020 | 5,400 | 8,100 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.96 per share. | 09 Dec 2020 | 5,400 | 6,404 (0%) | 0% | 60.0 | 323,784 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 100.39 per share. | 09 Dec 2020 | 4,593 | 1,811 (0%) | 0% | 100.4 | 461,077 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 100.64 per share. | 09 Dec 2020 | 2,870 | 3,042 (0%) | 0% | 100.6 | 288,837 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 101.43 per share. | 09 Dec 2020 | 2,038 | 1,004 (0%) | 0% | 101.4 | 206,714 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 101.47 per share. | 09 Dec 2020 | 807 | 1,004 (0%) | 0% | 101.5 | 81,886 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2020 | 5,050 | 5,600 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 103.00 per share. | 30 Nov 2020 | 5,050 | 5,912 (0%) | 0% | 103 | 520,150 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.93 per share. | 30 Nov 2020 | 5,050 | 10,962 (0%) | 0% | 41.9 | 211,747 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.93 per share. | 30 Nov 2020 | 3,350 | 12,201 (0%) | 0% | 41.9 | 140,466 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2020 | 3,350 | 10,650 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 103.40 per share. | 30 Nov 2020 | 3,350 | 8,851 (0%) | 0% | 103.4 | 346,397 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 103.00 per share. | 30 Nov 2020 | 2,939 | 5,912 (0%) | 0% | 103 | 302,717 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 103.36 per share. | 30 Nov 2020 | 2,061 | 8,851 (0%) | 0% | 103.4 | 213,025 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.87 per share. | 20 Nov 2020 | 9,040 | 19,952 (0%) | 0% | 39.9 | 360,425 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 9,040 | 3,860 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 101.51 per share. | 20 Nov 2020 | 9,040 | 10,912 (0%) | 0% | 101.5 | 917,640 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 101.54 per share. | 20 Nov 2020 | 5,000 | 10,912 (0%) | 0% | 101.5 | 507,713 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.87 per share. | 16 Nov 2020 | 6,400 | 27,312 (0%) | 0% | 39.9 | 255,168 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 6,400 | 12,900 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 96.29 per share. | 16 Nov 2020 | 6,400 | 20,912 (0%) | 0% | 96.3 | 616,250 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Sale of securities on an exchange or to another person at price $ 96.35 per share. | 16 Nov 2020 | 5,000 | 15,912 (0%) | 0% | 96.4 | 481,750 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 3,600 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.30 per share. | 16 Nov 2020 | 3,600 | 23,635 (0%) | 0% | 51.3 | 184,680 | Common Stock |
| Conmed Corp | Terence M. Berge | VP-Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.21 per share. | 16 Nov 2020 | 2,723 | 20,912 (0%) | 0% | 98.2 | 267,426 | Common Stock |